NCT04508972

Brief Summary

The VOICE-COVID study will evaluate the concordance of screening for symptoms of COVID-19 using a voice based device (Amazon Alexa) compared to manual screening by a study coordinator for individuals entering the Cardiology/Heart Failure clinic at the McGill University Health Centre.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
267

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2020

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 10, 2020

Completed
1 day until next milestone

First Posted

Study publicly available on registry

August 11, 2020

Completed
21 days until next milestone

Study Start

First participant enrolled

September 1, 2020

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2023

Completed
Last Updated

August 7, 2023

Status Verified

August 1, 2023

Enrollment Period

2.6 years

First QC Date

August 10, 2020

Last Update Submit

August 3, 2023

Conditions

Covid19

Keywords

COVID-19Alexa DeviceVoice-based technologiesScreeningSafety

Outcome Measures

Primary Outcomes (1)

  • Correlation between data captured using Amazon Alexa compared to manual (human) collected data.

    Determine the ability of the Amazon Alexa device to properly capture answers from participants and correlate with the answers retrieved by the study coordinator.

    Day 1

Other Outcomes (1)

  • Self reported Likert scale on comfort in using the Amazon Alexa device

    Day 1

Interventions

Alexa AmazonDEVICE

To test the use of the Amazon Alexa device as a tool to conduct screening of employees and patients at the point of entry into the Heart Failure (HF) Clinic of the McGill University Health Center.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Any employees or patients entering the Heart Failure clinic at the McGill University Health Center

You may qualify if:

  • Adults \>=18 yrs who is entering the HF clinic
  • Speaks either English or French

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Muhc-Rimuhc

Montreal, Quebec, H4A 3J1, Canada

Location

Related Publications (4)

  • Marques P, Emami A, Zhang G, Lopes RD, Razaghizad A, Avram R, Sharma A. Impact of age and comorbid heart failure on the utility of smart voice-assistant devices. Eur Heart J Digit Health. 2024 Feb 16;5(3):389-393. doi: 10.1093/ehjdh/ztae012. eCollection 2024 May.

    PMID: 38774370DERIVED

  • Sharma A, Marques P, Zhang G, Oulousian E, Chung SH, Ganni E, Lopes RD, Razaghizad A, Avram R. Voice-assisted Artificial Intelligence-enabled Screening for Severe Acute Respiratory Syndrome Coronavirus 2 Exposure in Cardiovascular Clinics: Primary Results of the VOICE-COVID-19-II Randomized Trial. J Card Fail. 2023 Oct;29(10):1456-1460. doi: 10.1016/j.cardfail.2023.05.004. Epub 2023 May 22.

    PMID: 37224994DERIVED

  • Oulousian E, Chung SH, Ganni E, Razaghizad A, Zhang G, Avram R, Sharma A. Voice-Based Screening for SARS-CoV-2 Exposure in Cardiovascular Clinics (VOICE-COVID-19-II): Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2023 Jan 31;12:e41209. doi: 10.2196/41209.

    PMID: 36719720DERIVED

  • Sharma A, Oulousian E, Ni J, Lopes R, Cheng MP, Label J, Henriques F, Lighter C, Giannetti N, Avram R. Voice-based screening for SARS-CoV-2 exposure in cardiovascular clinics. Eur Heart J Digit Health. 2021 Jun 16;2(3):521-527. doi: 10.1093/ehjdh/ztab055. eCollection 2021 Sep.

    PMID: 36713601DERIVED

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Study Officials

  • Abhinav Sharma, MD

    McGill University Health Centre/Research Institute of the McGill University Health Centre

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Cardiologist

Study Record Dates

First Submitted

August 10, 2020

First Posted

August 11, 2020

Study Start

September 1, 2020

Primary Completion

March 30, 2023

Study Completion

March 30, 2023

Last Updated

August 7, 2023

Record last verified: 2023-08

Locations

CA(1)